share_log

Luye Pharma Gets Marketing Go-Ahead for Lung Cancer Drug From Chinese Regulator

Luye Pharma Gets Marketing Go-Ahead for Lung Cancer Drug From Chinese Regulator

绿叶制药获得中国监管机构批准,用于肺癌药物的营销许可
MT Newswires ·  12/03 17:41

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发